Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- Handling of Adverse Reaction Data an Issue in Access System Adaptation: MHLW Deputy Director Miyata
March 28, 2012
- Eight Products/Indications Including Xalkori to Receive Formal Approval by End of Month
March 28, 2012
- Use of Medicoeconomic Assessment in Drug Pricing “Unrealistic”: DG for Policy Planning and Evaluation Katori
March 28, 2012
- MHLW Study Group Decides on Next 5-Year Plan for Activation of Clinical Research
March 27, 2012
- Council for Improvement of the Distribution of Ethical Drugs Agrees to Establish Working Team, Focus on Spreading “Mutual Understanding”
March 27, 2012
- “No Serious ADR” Found in MHLW’s Fixed-Point Observation for Byetta
March 27, 2012
- Council Approves 80 Development Requests from 2nd Round
March 27, 2012
- PMDA to Improve Review, Safety Standards to Become World-Class Regulatory Authority: Chief Executive Kondo
March 26, 2012
- Notification Calls for Revision of Package Inserts for Diabetes, MS Treatments
March 23, 2012
- Kawasaki’s Tonomachi District to Invite NIHS, Set to Become International Basis for R&D
March 23, 2012
- Eliminating Drug Lag Will Require Measures to Reduce “Application Lag”: Mr Akagawa of PFSB
March 22, 2012
- Council Meeting Considers Working Team to Explore Directions for Drug Distribution Improvement
March 21, 2012
- Pharmaceutical Industry Should be Fostered as “Core Industry Taxed Not Punished”: Mr Sengoku of DPJ
March 21, 2012
- CSIMC to Accelerate Discussions on Long-Listed Drugs, Cost-Benefit Assessments: Dr Suzuki of HIB
March 21, 2012
- Health Insurance Claims Services Releases 37 Additional Cases Based on “1980 Notice”
March 19, 2012
- Generics Not Listed in All Specifications to Be Delisted from April 1 with Some Exceptions
March 19, 2012
- MHLW Submits Application for Membership in PIC/S on March 9
March 19, 2012
- PMDA to Abolish Current Rule on Re-Employment of Its Former Employees
March 16, 2012
- Integration of Advanced Healthcare Service Systems “Not Related” to Compassionate Use System: Korosho
March 16, 2012
- Bill to Amend PAL Unlikely to Be Submitted in Current Diet Session Due to Time Constraints: Health Minister Komiyama
March 15, 2012
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…